• News

    • Latest news
    • Press releases
    • Upcoming events

Go back

Sakura Finetek USA launches a new webpage for the Genemed® brand of Advanced Staining products.

Publication    February 28, 2020    America, Global

February 28, 2020

Sakura Finetek USA launches a new webpage for the Genemed® brand of Advanced
Staining products.

Contact: Erico von Bueren, Director of Marketing

TORRANCE, CA – Sakura Finetek USA, Inc. today announced the launch of a new Genemed
webpage for advanced staining products.

“Immunohistochemistry has evolved from an antigen specific affinity purification antibody to
the current state-of-the art rabbit monoclonal antibody expressed in mammalian cell cultures.
The Genemed product portfolio has co-evolved with the technology to offer the highest
quality products to provide optimal stain quality” said Mr. Luu, Senior Vice President of
Sakura Bioscience. “The new webpage gives our customers easy and quick access to quality
antibodies, detection systems and ancillary reagents that improve the accuracy of diagnostic
information that benefit the health of all patients” stated William Jennings, Senior Product
Manager of Advanced Staining.

About Genemed

Genemed IHC products offer you innovation that can only come from a company whose focus
since 1987 has been geared toward producing clinically relevant antibodies for anatomic
pathology. The Genemed antibody portfolio offers a broad range of primary antibodies
suitable for immunohistochemistry (IHC) on formalin-fixed paraffin embedded (FFPE) tissue
specimens. We primarily focus on in vitro diagnostics (IVD), which includes antibodies,
detection systems, and ancillary reagents for clinical testing in histopathology laboratories.

About Sakura Finetek USA, Inc.

With its U.S. office based in Torrance, California, Sakura Finetek is the global leader in
advancing cancer diagnostics by providing integrated solutions for anatomic pathology and patient treatment through best-in-class innovation, quality and customer care. With a strategic
focus on end-to-end automation, Sakura Finetek continues to lead the industry in the
development and commercialization of automated histopathology instrumentation and
consumables for anatomic pathology.

Sakura Finetek systems dramatically increase efficiency, standardize results, and enable
pathology laboratories to more simply manage their daily workload while significantly
impacting patient care. Visit www.sakuraus.com to learn more.

Erico von Bueren
Director of Marketing
Sakura Finetek USA, Inc.
1750 W. 214th St.
Torrance, CA 90501
evonbueren@sakuraus.com

“Immunohistochemistry has evolved from an antigen specific affinity purification antibody to the current state-of-the art rabbit monoclonal antibody expressed in mammalian cell cultures. The Genemed product portfolio has co-evolved with the technology to offer the highest quality products to provide optimal stain quality” said Mr. Luu, Senior Vice President of Sakura Bioscience. 

Download PDF

Print

MPRE0051 Rev.A